tm
Seeing Is Believing
tm
Seeing Is Believing
RNAC is currently covered by 3 analysts with an average price target of $34.84. This is a potential upside of $24.52 (237.6%) from yesterday's end of day stock price of $10.32.
Cartesian Therapeutics's activity chart (see below) currently has 0 price targets and 25 ratings on display. The stock rating distribution of RNAC is 96% BUY and 4% HOLD.
Highest price target for RNAC is $45, Lowest price target is $41, average price target is $43.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 28-Jan-2025. First documented stock forecast 23-Apr-2024.
Currently out of the existing stock ratings of RNAC, 24 are a BUY (96%), 1 are a HOLD (4%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$45
$34.58 (331.86%)
$45
4 months 19 days ago
(28-Jan-2025)
0/11 (0%)
$25.01 (125.11%)
Buy
$41
$30.58 (293.47%)
$41
4 months 20 days ago
(27-Jan-2025)
0/10 (0%)
$21.58 (111.12%)
Hold
$50
11 months 14 days ago
(02-Jul-2024)
0/3 (0%)
$26.96 (117.01%)
What is RNAC (Cartesian Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RNAC (Cartesian Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RNAC (Cartesian Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most bullish on RNAC (Cartesian Therapeutics)?
Which analyst is the currently most reserved on RNAC (Cartesian Therapeutics)?
